Overview

Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)

Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
To estimate the efficacy of combination therapy with Lantus plus Amaryl in controlling blood glucose in Japanese patients with type 2 diabetes having failed OAD therapy, and document the ability to preserve the endocrine pancreatic function with Lantus plus Amaryl combination therapy
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Glimepiride
Insulin
Insulin Glargine